Therefore, we speculated that apatinib promoted ROS generation to inhibit NSCLC by targeting Nrf2 and ROS exerted a critical role in apatinib-induced apoptosis in NSCLC. Here, NFE2L2 is linked to non-small cell lung carcinoma.